Combination therapy in dyslipidemia: Where are we now?-Reference-Cited by-同舟云学术

Combination therapy in dyslipidemia: Where are we now?

Published:2014-11 Issue:1 Volume:237 Page:319-335
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Catapano Alberico L.,Farnier Michel,Foody JoAnne M.,Toth Peter P.,Tomassini Joanne E.,Brudi Philippe,Tershakovec Andrew M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference196 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult;Anderson;Can. J. Cardiol.,2013

3. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan – 2012 version;Teramoto;J. Atheroscler. Thromb.,2013

4. Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease;National Institute for Health and Care Excellence,2014

5. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials;Mihaylova;Lancet,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin Intolerance: An Overview for Clinicians;Contemporary Diabetes;2023

2. The effect of Brassica vegetables on blood glucose levels and lipid profiles in adults. A systematic review and meta‐analysis;Phytotherapy Research;2022-04-12

3. Antihyperlipidemic Effects of Methanol Extract of Seeds of Citrullus lanatus in Hyperlipidemic Rats;Pakistan Journal of Zoology;2022

4. Cholesterol-to-Coprostanol Conversion by the Gut Microbiota: What We Know, Suspect, and Ignore;Microorganisms;2021-09-05

5. Guía ESC/EAS 2019 sobre el tratamiento de las dislipemias: modificación de los lípidos para reducir el riesgo cardiovascular;Revista Española de Cardiología;2020-05